Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

61d73eb0bcf0262f4a194b5b9c4423d82294b55199c4d8d5be8e4f3e69875b65

Total Revenue (USD, thousands)

Cost of Goods Sold (COGS) (USD, thousands)

Selling, General, and Administrative Expenses (SG&A) (USD, thousands)

Research and Development (R&D) (USD, thousands)

Depreciation and Amortization (D&A) (USD, thousands)

Interest Expense (USD, thousands)

Operating Income (EBIT) (USD, thousands)

Net Income (USD, thousands)

Earnings Per Share (EPS) - Basic (USD)

Earnings Per Share (EPS) - Diluted (USD)

1a1998242c70cf1f76047fa583b0132a71090ab0b444e032222b6003b8bb8929

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

0deda04b88ffa1b7e6b8a1d7c16aac0529747669e6ac965273d5d16e9889204b

Cash and cash equivalents (USD, thousands)

Marketable securities (USD, thousands)

Accounts receivable (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Property and equipment, net (USD, thousands)

Operating lease right-of-use asset (USD, thousands)

Intangible assets, net (USD, thousands)

Restricted cash (USD, thousands)

Other noncurrent assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses and other current liabilities (USD, thousands)

Operating lease liability, current (USD, thousands)

Total current liabilities (USD, thousands)

Deferred tax liability (USD, thousands)

Operating lease liability, noncurrent (USD, thousands)

Warrant liabilities (USD, thousands)

Other noncurrent liabilities (USD, thousands)

Total liabilities (USD, thousands)

Common stock (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated other comprehensive income (loss) (USD, thousands)

Accumulated deficit (USD, thousands)

Total stockholders' equity (USD, thousands)

Total liabilities and stockholders' equity (USD, thousands)

7ee0fe880c9fb0cb0b138ffe1b0477d3d27400c255068da1da75ca7b8d42cd16

Research and Development Expenses (USD, thousands)

General and Administrative Expenses (USD, thousands)

Total Operating Expenses (USD, thousands)

Loss from Operations (USD, thousands)

Interest Income (USD, thousands)

Other Income (Expense), Net (USD, thousands)

Change in Fair Value of Warrant Liabilities and Contingent Earn-Out Shares (USD, thousands)

Total Other Income, Net (USD, thousands)

Loss Before Income Taxes (USD, thousands)

Net Loss (USD, thousands)

Net Loss Per Share attributable to common stockholders, basic and diluted (USD)

Weighted-average common shares used to compute net loss per share, basic and diluted

f3f8e061e32a059b37c58145865e3ba0eebd39cb1e11e057ef4225f9c9d63208

7841fdf08c29bd7d910d770066280139e22c23cac4252644573eccf733da1786

Collaboration Revenue

Total Revenue

a09c43c7bfedc1857abf6da7a90cb138d638e6d6feade8f4bb964e25ef8cab1f

Revolution Medicines Inc (RVMD)

Financials